Why Price Transparency Matters for Weight Management Medications
Wegovy Compared to Mounjaro: The Hidden Fee Problem
When comparing Wegovy to Mounjaro online, patients often encounter misleading pricing structures that make informed decisions impossible. Many UK pharmacies advertise low medication prices, then add consultation fees (£25-£50), prescription charges (£15-£30), and handling costs at checkout. This practice particularly affects weight management medications, where patients need ongoing monthly supplies and predictable budgeting. EverydayMeds eliminates this confusion entirely.
Our transparent approach means Wegovy prices from £79.99 and Mounjaro options include every service fee upfront. Whether you choose semaglutide (Wegovy's GLP-1 mechanism) or tirzepatide (Mounjaro's dual GIP/GLP-1 approach), you'll know your exact monthly costs from day one. This transparency becomes crucial when planning long-term weight management, as both medications require consistent use alongside a reduced-calorie diet and increased physical activity.
Complete Wegovy vs Mounjaro Pricing Breakdown
Understanding the true cost comparison between Wegovy and Mounjaro requires seeing all-inclusive pricing. Wegovy starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. These prices include clinical assessment, MHRA-registered prescriber review, prescription issuance, and next-day cold-chain delivery. New customers apply code FIRST40 at checkout, while returning patients use DOSE25.
Our Getting Started bundles provide additional convenience for the dose escalation phase required with both treatments. The Intro Duo (0.25mg & 0.5mg Wegovy) costs £169.99, while the Progress Trio (0.5mg, 1mg & 1.7mg) is £369.99. Each bundle includes the same comprehensive service package, eliminating multiple orders and ensuring treatment continuity. This pricing structure applies equally whether you're prescribed Wegovy or Mounjaro following your clinical assessment.
Clinical Evidence: Wegovy Compared to Mounjaro Trials
Both medications demonstrate significant efficacy in clinical trials, though direct comparisons aren't possible due to different study designs and populations. The STEP programme showed patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial confirmed this effect sustained at approximately 15.2% after two years of treatment.
Mounjaro's SURMOUNT trials demonstrated the dual GIP/GLP-1 mechanism's potential, though comparing percentage outcomes directly would be inappropriate given different trial methodologies. Both treatments require prescription-only access through licensed UK pharmacies like EverydayMeds (GPhC #9012878), with identical clinical assessment requirements regardless of which medication your prescriber recommends.
How Wegovy Works When Compared to Mounjaro Mechanisms
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, reducing appetite and promoting satiety after smaller meals. This single-pathway approach targets brain appetite centres directly, potentially reducing food cravings throughout the week following your once-weekly injection. Mounjaro uses tirzepatide, a dual GIP and GLP-1 receptor agonist, engaging two hormone pathways simultaneously for appetite control. Both mechanisms work optimally when combined with lifestyle modifications, as neither replaces the need for dietary changes and increased physical activity. Your prescriber will consider factors like your medical history, current medications, and treatment goals when choosing between these approaches.
Ordering Process: Wegovy Compared to Mounjaro Assessment
EverydayMeds uses an identical clinical assessment process whether you're considering Wegovy or Mounjaro, ensuring consistent medical oversight for both prescription-only medicines. The 3-minute online questionnaire covers your medical history, current medications, weight management goals, and any contraindications specific to GLP-1 treatments. Our MHRA-registered prescribers review applications within 3 working days (or 24 hours with express service), determining which medication suits your individual circumstances. Once approved, both treatments ship via next-day delivery using cold-chain storage to maintain medication integrity. This standardised process ensures equal clinical rigour whether you receive semaglutide or tirzepatide therapy.
Storage Differences: Wegovy Compared to Mounjaro Practical Considerations
Storage requirements present one practical difference when comparing Wegovy to Mounjaro for long-term treatment planning. Wegovy pens maintain stability for 6 weeks at room temperature below 30°C once removed from refrigeration, offering superior travel flexibility compared to Mounjaro's 21-day room temperature limit. Both require refrigerated storage (2-8°C) before first use, arriving in temperature-controlled packaging to ensure medication quality. The FlexTouch pen system used by Wegovy provides consistent dosing through the mandatory escalation schedule: 0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance. Neither medication allows dose-skipping, making reliable storage and supply chain management essential for treatment success.
Wegovy Compared to Mounjaro: Why Fee Transparency Matters Most
The weight management medication market suffers from widespread pricing opacity, with patients discovering true costs only at checkout after completing lengthy assessments. This practice particularly disadvantages those budgeting for long-term treatment, as both Wegovy and Mounjaro require ongoing monthly prescriptions for sustained results. EverydayMeds pioneered all-inclusive pricing specifically to address this problem, recognising that treatment decisions deserve complete financial clarity.
Our commitment extends beyond initial prescription costs to ongoing treatment phases, with maintenance dosing prices clearly displayed and bundle options providing supply security. Whether your prescriber recommends Wegovy's proven GLP-1 approach or Mounjaro's dual-pathway mechanism, you'll understand your monthly investment from day one. This transparency proves especially valuable given that STEP trial data shows patients regained approximately two-thirds of lost weight within one year of stopping treatment, emphasising the long-term financial commitment required.
Start Your Wegovy or Mounjaro Journey: Complete Price Certainty
Both Wegovy and Mounjaro are available from EverydayMeds with identical transparent pricing structures, eliminating guesswork from your treatment decision. Your clinical assessment will determine which medication aligns with your medical profile, while our upfront pricing ensures budget certainty regardless of the recommendation. New customers use code FIRST40 at checkout, with returning patients applying DOSE25 to access our advertised rates. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment, knowing that your quoted price includes every service from clinical review through cold-chain delivery. Our GPhC-registered pharmacy (#9012878) maintains the same rigorous standards for both treatments, supporting your weight management goals with complete transparency.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
